Utility of therapeutic drug monitoring of venetoclax in acute myeloid leukemia Masayuki KobayashiTakeo YasuNobuharu Kosugi Original Paper 12 October 2022 Article: 259
Therapeutic landscape of advanced HER2-positive breast cancer in 2022 Ruby GuptaSachin GuptaIshmael Jaiyesimi Review Article 12 October 2022 Article: 258
HDAC inhibitor Vorinostat and BET inhibitor Plx51107 epigenetic agents’ combined treatments exert a therapeutic approach upon acute myeloid leukemia cell model İlayda AlcitepeHilal SalcinBurcin Tezcanli Kaymaz Original Paper 12 October 2022 Article: 257
Identification and analysis of dysregulated fatty acid metabolism genes in breast cancer subtypes Umar YousufShazia SofiManzoor Ahmad Mir Original Paper 12 October 2022 Article: 256
Investigation of molecular mechanisms underlying JAK/STAT signaling pathway in HPV-induced cervical carcinogenesis using ‘omics’ approach Kulbhushan ThakurDivya JanjuaAlok Chandra Bharti Original Paper 12 October 2022 Article: 255
NDR1 activates CD47 transcription by increasing protein stability and nuclear location of ASCL1 to enhance cancer stem cell properties and evasion of phagocytosis in small cell lung cancer Ling-Ling WangXiao-Yun WanFei-Meng Zheng Original Paper 12 October 2022 Article: 254
5-FU and the dietary flavonoid carvacrol: a synergistic combination that induces apoptosis in MCF-7 breast cancer cells Saleh AzimiHamed Esmaeil LashgarianHassan Dariushnejad Original Paper 12 October 2022 Article: 253
In vitro cytotoxicity and anti-cancer drug release behavior of methionine-coated magnetite nanoparticles as carriers Faten Eshrati YeganehAmir Eshrati YeganehMuhammad Safdar Original Paper 12 October 2022 Article: 252
Morin inhibits colon cancer stem cells by inhibiting PUM1 expression in vitro Ravi GorLinkon SahaSatish Ramalingam Original Paper 12 October 2022 Article: 251
PRDX6 knockout restrains the malignant progression of intrahepatic cholangiocarcinoma Hong LiZhengsheng WuYuxian Shen Original Paper Open access 08 October 2022 Article: 250
Insilco and Invitro approaches identify novel dual PI3K/AKT pathway inhibitors to control acute myeloid leukemia cell proliferations Mohammad AbohassanMesfer AlshahraniPrasanna Rajagopalan Original Paper 08 October 2022 Article: 249
Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K/Akt/mTOR pathway Preeti SharmaMohammad Ahmed KhanMohd Akhtar Review Article 08 October 2022 Article: 248
Hepatocellular carcinoma stage: an almost loss of fatty acid metabolism and gain of glucose metabolic pathways dysregulation Karthik Balakrishnan Original Paper 08 October 2022 Article: 247
Targeting aurora kinase a (AURKA) in cancer: molecular docking and dynamic simulations of potential AURKA inhibitors Abdullah Almilaibary Original Paper 30 September 2022 Article: 246
The role of nutrition in harnessing the immune system: a potential approach to prevent cancer Hu XiaogangMonika SharmaEl-Sayed Salama Review Article 30 September 2022 Article: 245
The circadian clock gene ARNTL overexpression suppresses oral cancer progression by inducing apoptosis via activating autophagy Hanxue LiMeng LiZhi Zhou Original Paper 30 September 2022 Article: 244
β-Asarone suppresses TGF-β/Smad signaling to reduce the invasive properties in esophageal squamous cancer cells Yi HuZhenmei LiZhe Song Original Paper 30 September 2022 Article: 243
IKZF3 amplification frequently occurs in HER2-positive breast cancer and is a potential therapeutic target Chih-Yi LinChung-Jen YuJiun-I Lai Original Paper 30 September 2022 Article: 242
Recent advances in cancer therapy using PARP inhibitors Simran Deep KaurDinesh Kumar ChellappanDeepak N. Kapoor Review Article 30 September 2022 Article: 241
Niosomes: a novel targeted drug delivery system for cancer Maryam MoghtaderiKamand SedaghatniaBahareh Farasati Far Review Article 29 September 2022 Article: 240
Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies Jabar A. FarajAli Jihad Hemid Al-AthariAbduladheem Turki Jalil Review Article 29 September 2022 Article: 239
Tissue proteome analysis revealed an association between cancer, immune system response, and the idiopathic granulomatous mastitis Merve Gulsen Bal AlbayrakTurgay SimsekSertac Ata Guler Original Paper 29 September 2022 Article: 238
Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer Geetha ShanmugamSumana DasKoustav Sarkar Review Article 29 September 2022 Article: 237
The past, present, and future of immunotherapy for bladder tumors Theresa SchneiderLei ZhaoYujiang Fang Review Article 29 September 2022 Article: 236
The functions of N6-methyladenosine (m6A) RNA modifications in colorectal cancer Haiyan QiaoLinfeng LiuLiang Wang Review Article 29 September 2022 Article: 235
YM155 and chrysin cooperatively suppress survivin expression in SMARCB1/INI1-deficient tumor cells Yuki YoshinoHiroaki GotoMasakatsu Yanagimachi Original Paper 29 September 2022 Article: 234
Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer Thejeswar NakkaLuxitaa GoenkaPrasanth Ganesan Short Communication 29 September 2022 Article: 233
The challenge of selecting tumor antigens for chimeric antigen receptor T-cell therapy in ovarian cancer Haigang DingJuan ZhangQingping Li Review Article 29 September 2022 Article: 232
WTAP promotes oesophageal squamous cell carcinoma development by decreasing CPSF4 expression in an m6A-dependent manner Qian LuoXuebing ZhanBing Chen Original Paper 29 September 2022 Article: 231
TNFAIP3 promotes ALDH-positive breast cancer stem cells through FGFR1/MEK/ERK pathway Wanru FengMengdi GaoTao He Original Paper 29 September 2022 Article: 230
Effect of pre-low-dose irradiation on anticancer activities of gallic acid in leukemic K562 and K562/Dox cells: cell viability and cellular energetic state studies Khin TheNu AyeSakornniya WattanapongpitakMontree Tungjai Original Paper 29 September 2022 Article: 229
Are we overtreating stage I triple-negative breast cancer in Ontario? A population-based retrospective epidemiological analysis using the ICES database Kathryn ShumAbdulkadir HusseinCaroline Hamm Original Paper 29 September 2022 Article: 228
Glutamine stabilizes myc via alpha-ketoglutarate and regulates paclitaxel sensitivity Vikas BhardwajJun HeAditi Jain Original Paper 29 September 2022 Article: 227
Targeting MDC1 promotes apoptosis and sensitizes Imatinib resistance in CML cells by mainly disrupting non-homologous end-joining repair Yang LiangYuefeng QinYing Yuan Original Paper 29 September 2022 Article: 226
Extracellular vesicle-based checkpoint regulation and immune state in cancer Keywan MortezaeeJamal Majidpoor Review Article 29 September 2022 Article: 225
Does immunotherapy change the treatment paradigm in metastatic gastric cancer? Silvia CameraNicole LisciaStefano Cascinu Review Article 29 September 2022 Article: 224
Philadelphia-negative myeloproliferative neoplasms display alterations in monocyte subpopulations frequency and immunophenotype Vitor Leonardo BassanGabriel Dessotti BarrettoFabÃola Attié de Castro Original Paper 29 September 2022 Article: 223
Correction: Expression of caveolin-1 is correlated with lung adenocarcinoma proliferation, migration, and invasion Tian-Yan LuanTie-Nian ZhuRui-Jing Zhao Correction 29 September 2022 Article: 222
The natural medicinal fungus Huaier promotes the anti-hepatoma efficacy of sorafenib through the mammalian target of rapamycin-mediated autophagic cell death Zhengguang ZhangCunsi ShenFuqiong Zhou Original Paper 29 September 2022 Article: 221
Anti-cancer activity of human gastrointestinal bacteria Sameer Quazi Review Article 29 September 2022 Article: 220
Evaluation of lung adverse events with trastuzumab using the Japanese pharmacovigilance database Yuko KanbayashiMayako UchidaTadashi Shimizu Original Paper 29 September 2022 Article: 219
Association between cancer genes and germ layer specificity Hwayeong LeeSungwhan LeeLeeyoung Park Original Paper 29 September 2022 Article: 218
Anti-tumor effect of berberine on chronic lymphocytic leukemia cells Maryam AbdollahiMaryam MohammadlouParviz Kokhaei Original Paper 29 September 2022 Article: 217
Panobinostat (LBH589) increase survival in adult xenografic model of acute lymphoblastic leukemia with t(4;11) but promotes antagonistic effects in combination with MTX and 6MP Daniel Antunes MorenoHoward Lopes Ribeiro JuniorLuiz Gonzaga Tone Original Paper 29 September 2022 Article: 216
TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy Sameer Quazi Review Article 29 September 2022 Article: 215
SPLUNC1 regulates LPS-induced progression of nasopharyngeal carcinoma and proliferation of myeloid-derived suppressor cells Ling TangLing PengPan Chen Original Paper 29 September 2022 Article: 214
Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer Rui HanHongxing YangLingeng Lu Original Paper Open access 29 September 2022 Article: 213
Transcription factor SOX3 upregulated pro-apoptotic genes expression in human breast cancer Felipe Henrique de Souza SilvaAdam UnderwoodHelen Lima Del Puerto Original Paper 29 September 2022 Article: 212
Moxidectin induces autophagy arrest in colorectal cancer Yushan MaoHanhan XieKejian Pan Original Paper 29 September 2022 Article: 211
The role of HER2 alterations in clinicopathological and molecular characteristics of breast cancer and HER2-targeted therapies: a comprehensive review Shafighe Asgari-KarchekaniArmin AryannejadSeyed Mohammad Tavangar Review Article 29 September 2022 Article: 210